Skip to content

13F-HR filed by Finepoint Capital LP

Finepoint Capital LP filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-13, with 10 holding rows worth $1,355,564,277.

Accession
0000904454-25-000412
Filed
2025-08-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2025

A holdings report, 10 entries on the cover page, a total value of $1,355,564,277 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,355,564,277 with VALUE read as dollars as filed, 13F file number 028-16580. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS1,173,500$725,046,975dollars as filedput
QXO INC COM NEW82846H405Stock21,152,868$455,632,777dollars as filed
iShares Russell 2000 ETF464287655SHS585,000$126,237,150dollars as filedput
LIBERTY MEDIA CORP DEL531229722COM LBTY LIV S C537,051$43,587,059dollars as filed
SOLID BIOSCIENCES INC83422E204COMMON STOCK961,251$4,681,292dollars as filed
ALEANNA INC01444V103COM CL A27,717$199,562dollars as filed
ALEANNA INC01444V111*W EXP 12/13/202490,000$115,150dollars as filed
MONEYHERO LIMITEDG6202B119*W EXP 09/13/202895,000$41,886dollars as filed
SUMMIT HEALTHCARE ACQUISITIONg9845f117WT489,999$19,551dollars as filed
CALIDI BIOTHERAPEUTICS INC320703309COM NEW12,499$2,875dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000904454-25-000412this filing2025-08-13acceptance time not in the bulk data set